Picture of Atara Biotherapeutics logo

ATRA Atara Biotherapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for Atara Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-231-291-307-340-228
Depreciation
Non-Cash Items32.252.453.857.713.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital15-4.1563.752.6-61.5
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-180-236-181-221-270
Capital Expenditures-35.9-5.73-4.51-10.6-4.19
Purchase of Fixed Assets
Other Investing Cash Flow Items-16066.2-11632.8207
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-19660.5-12122.3203
Financing Cash Flow Items17.20.6554.995.531.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities35818942810453.1
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-18.513.6126-94.3-14.4